Smoking History and Response to Nivolumab in Patients with Advanced NsclcsMatthew D. Hellmann, Naiyer A. Rizvi, Wade T. Iams et al.|Annals of Oncology|2014Cited by 32
Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung CancerCasey Liveringhouse, Bradford A. Perez, Kujtim Latifi et al.|International Journal of Radiation Oncology*Biology*Physics|2023Cited by 18